Missing/wrong data?
Log in to edit
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice
scientific article published on 23 July 2020
Author/s
author: Saad Shakir
Work details
Publication date
July 23, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.